Delhi-Based Varco Leg Care Secures Funding to Enhance Treatment Adherence

The funds will be utilised towards talent acquisition, expanding the company's retail presence, enhancing treatment adherence, advancing research and development activities, and improving customer retention strategies.

Delhi-based Varco Leg Care, a healthtech startup focusing on leg-related issues, has secured a bridge funding round, raising INR 2 Cr to further its growth strategies.

The round was led by Neeraj Garg, former CEO of Hindustan Coca-Cola with participation from existing and new investors. Besides, senior executives from Coca-Cola, Emporia UAE, Highway Concessions One, a KKR company, and a group of high-net-worth individuals also were part of this round.

The funds will be utilised towards talent acquisition, expanding the company's retail presence, enhancing treatment adherence, advancing research and development activities, and improving customer retention strategies, as per the startup.

Founded in 2022 by Anondeep Ganguly, Varco Leg Care specialises in addressing various leg-related ailments, such as spider veins, varicose veins, diabetic foot conditions, and restless leg syndrome.

The startup relies on advanced plant molecule technology, utilising topical applications and capsules for highly effective treatments.

Varco Leg Care's strategic vision revolves around creating a comprehensive range of leg care products. It aims to solidify its footprint in the US market by collaborating with leading marketplaces and expanding into new territories, including the GCC countries.

Varco Leg Care claims to have exceeded $1 million in its total revenue with more than 300,000 customers and 1,500 pharmacies in Mumbai, Bengaluru, and Delhi. The startup has set ambitious targets, striving for a tenfold increase in its monthly recurring revenue.

In other recent funding news, Bengaluru-based Sugar.fit secured $11 million in a Series A funding round, with MassMutual Ventures taking the lead. This round also saw contributions from existing investors, including Cure.fit, Tanglin Venture Partners, and Endiya Partners.

Meanwhile, Bengaluru-based Leucine Rich Bio recently secured Pre-Series A funding to drive innovation in healthcare product development and strengthen its research and development capabilities.

Additionally, Gurugram-based healthtech startup Curelo secured $100,000 in funding from the Indian Institute of Management (IIM) Ahmedabad's CIIE.CO, aimed at streamlining at-home blood sample collections and ensuring swift access to patient blood reports.